Inhaled LTI-03 for idiopathic pulmonary fibrosis: a randomized dose escalation study.

Molyneaux PL, Hirani NA, Chia CCK, Kulkarni T, Zaman T, Kaner RJ, Coelho AL, Jannini-Sa YAP, Windsor B, Kruger S, Christensen DJ, Shoemaker SA, Hogaboam CM, MacKenzie B, Günther A

Open source

DOI
10.1038/s41467-026-75291-3
Published
2026 Jul 31
Container
Nature communications
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41467-026-75291-3,
  title = {Inhaled LTI-03 for idiopathic pulmonary fibrosis: a randomized dose escalation study.},
  author = {Molyneaux PL and Hirani NA and Chia CCK and Kulkarni T and Zaman T and Kaner RJ and Coelho AL and Jannini-Sa YAP and Windsor B and Kruger S and Christensen DJ and Shoemaker SA and Hogaboam CM and MacKenzie B and Günther A},
  year = {2026},
  journal = {Nature communications},
  doi = {10.1038/s41467-026-75291-3},
  url = {https://doi.org/10.1038/s41467-026-75291-3}
}

RIS

TY  - JOUR
TI  - Inhaled LTI-03 for idiopathic pulmonary fibrosis: a randomized dose escalation study.
AU  - Molyneaux PL
AU  - Hirani NA
AU  - Chia CCK
AU  - Kulkarni T
AU  - Zaman T
AU  - Kaner RJ
AU  - Coelho AL
AU  - Jannini-Sa YAP
AU  - Windsor B
AU  - Kruger S
AU  - Christensen DJ
AU  - Shoemaker SA
AU  - Hogaboam CM
AU  - MacKenzie B
AU  - Günther A
PY  - 2026
JO  - Nature communications
DO  - 10.1038/s41467-026-75291-3
UR  - https://doi.org/10.1038/s41467-026-75291-3
ER  - 

APA

PL, M., NA, H., CCK, C., T, K., T, Z., RJ, K., AL, C., YAP, J., B, W., S, K., DJ, C., SA, S., CM, H., B, M., & A, G. (2026). Inhaled LTI-03 for idiopathic pulmonary fibrosis: a randomized dose escalation study.. Nature communications. https://doi.org/10.1038/s41467-026-75291-3

Source records